Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / February / The Most Sensitive Cancer Blood Test Yet
Oncology Liquid biopsy Point of care testing Screening and monitoring Training and education Research and Innovations Molecular Pathology

The Most Sensitive Cancer Blood Test Yet

A CRISPR-powered light sensor detected trace amounts of cancer biomarkers in the blood

02/24/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Oncology Diagnostics and Liquid Biopsy

Leading institutions in oncology diagnostics and liquid biopsy research combine expertise in molecular biology, nanotechnology, optical sensing, and CRISPR technology to develop and validate highly sensitive assays for early cancer detection and treatment monitoring.

  • #1

    Dana-Farber Cancer Institute

    Boston, MA

    Dana-Farber is a world leader in cancer research and precision oncology, with extensive programs in liquid biopsy development and clinical translation of novel cancer diagnostics.

    Key Differentiators

    • Oncology
    • Molecular Diagnostics
    • Liquid Biopsy
  • #2

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC has a robust translational research program focused on circulating tumor DNA and microRNA biomarkers, integrating cutting-edge molecular techniques with clinical oncology.

    Key Differentiators

    • Cancer Biology
    • Molecular Diagnostics
    • Liquid Biopsy
  • #3

    Stanford University School of Medicine

    Stanford, CA

    Stanford excels in integrating nanotechnology, optical sensing, and molecular biology to innovate ultra-sensitive diagnostic platforms for cancer detection.

    Key Differentiators

    • Biomedical Engineering
    • Oncology
    • Nanotechnology
  • #4

    Johns Hopkins University School of Medicine

    Baltimore, MD

    Johns Hopkins has a history of innovation in cancer biomarker discovery and development of sensitive molecular diagnostic assays, including microRNA-based tests.

    Key Differentiators

    • Cancer Biology
    • Molecular Diagnostics
    • Biomedical Engineering
  • #5

    Massachusetts Institute of Technology (MIT)

    Cambridge, MA

    MIT leads in nanomaterials and optical biosensing technologies, including DNA origami and quantum dot applications relevant to ultra-sensitive cancer diagnostics.

    Key Differentiators

    • Nanotechnology
    • Biomedical Engineering
    • Molecular Diagnostics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.